Open Actively Recruiting

Metformin Treatment in Progressive Multiple Sclerosis

About

Brief Summary

The purpose of this study is to assess the safety of metformin for treatment of progressive multiple sclerosis

Primary Purpose
Treatment
Study Type
Interventional
Phase
Early Phase 1

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
30 Years
Maximum Age
65 Years

Inclusion Criteria:

Exclusion Criteria:

Join this Trial

Share:
Study Stats
Protocol No.
22-000020
Category
Brain/Neurological Diseases
Contact
Kevin Patel
Location
  • UCLA Westwood
For Providers
NCT No.
NCT05349474
For detailed technical eligibility, visit ClinicalTrials.gov.